Nicole Tidd
Adult Health · Orangeburg, SCNPI 1700295284
Payments from drug & device makers
Across 78 payments — averaging $19.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$238
- Merck$191
- Johnson & Johnson$172
- AstraZeneca$148
- Lexicon Pharmaceuticals, Inc.$124
- Boehringer Ingelheim$117
- plus $518 from 12 others
What the payments were for
- Food & beverage$1,508100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 14 | $238 |
| Merck | 13 | $191 |
| Johnson & Johnson | 11 | $172 |
| AstraZeneca | 3 | $148 |
| Lexicon Pharmaceuticals, Inc. | 1 | $124 |
| Boehringer Ingelheim | 7 | $117 |
| Novartis | 8 | $109 |
| Abbott | 3 | $88 |
| Daiichi Sankyo Inc. | 3 | $60 |
| E.r. Squibb & Sons, L.L.C. | 3 | $52 |
| Sanofi-aventis U.S. LLC | 3 | $45 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $34 |
| Medicomp Inc | 1 | $29 |
| Edwards Lifesciences | 1 | $27 |
| Boston Scientific | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| Cvrx, Inc. | 1 | $15 |
| Preventice Services, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,508 in reported general payments places this provider in the 60th percentile of 292 adult health providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 317 | $213,687 |
| EntrestoSacubitril/Valsartan | 151 | $120,993 |
| JardianceEmpagliflozin | 84 | $56,961 |
| FarxigaDapagliflozin Propanediol | 43 | $39,358 |
| XareltoRivaroxaban | 24 | $16,301 |
| BrilintaTicagrelor | 11 | $4,850 |
| Metoprolol Succinate | 283 | $2,153 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 177 | $1,941 |
| Ranolazine ErRanolazine | 23 | $1,841 |
| ClopidogrelClopidogrel Bisulfate | 124 | $1,455 |
| Atorvastatin Calcium | 108 | $1,372 |
| Carvedilol | 155 | $1,260 |
| Metoprolol Tartrate | 253 | $1,221 |
| Amiodarone Hcl | 25 | $991 |
| Nitroglycerin | 43 | $855 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $238 | $213,687317 claims |
| NovartisEntresto | $109 | $120,993151 claims |
| Boehringer IngelheimJardiance | $117 | $56,96184 claims |
| AstraZenecaFarxiga, Brilinta | $148 | $44,20954 claims |
| Johnson & JohnsonXarelto | $172 | $16,30124 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 292 adult health providers in South Carolina.
Other adult health in Orangeburg
- Karen RobertsonGreenville$69K
- Christine FranzeseTega Cay$30K
- Jessica RiceGreenville$15K
- Michelle PriceCharleston$13K
- Melissa McCarterSpartanburg$12K
- Andrea OlsonWest Columbia$12K
- Jennifer BrittIrmo$11K
- Nichole SnowSpartanburg$10K
- Christi WigginsWest Columbia$10K
- Mary BairdSumter$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.